Clinical and genetic aspects of testicular germ cell tumours
| Autor: | Rolf H. Sijmons, Dirk Sleijfer, Josette E. H. M. Hoekstra-Weebers, Harald J. Hoekstra, Martijn F. Lutke Holzik |
|---|---|
| Přispěvatelé: | Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Psychology Research (HPR) |
| Jazyk: | angličtina |
| Rok vydání: | 2008 |
| Předmět: |
Oncology
medicine.medical_specialty Pathology Down syndrome lcsh:QH426-470 Somatic cell review CANCER-PATIENTS DEVELOPMENTAL ANOMALIES SUSCEPTIBILITY DOWNS-SYNDROME lcsh:RC254-282 INFERTILITY Germline mutation testicular germ cell tumour Internal medicine Genetic predisposition Medicine genetics Family history Genetics (clinical) RISK therapy business.industry TESTIS Carcinoma in situ LONG-TERM SURVIVORS familial Seminoma lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease SOLID TUMORS Human genetics lcsh:Genetics CARCINOMA IN-SITU business |
| Zdroj: | Hereditary Cancer in Clinical Practice, Vol 6, Iss 1, Pp 3-14 (2008) Hereditary Cancer in Clinical Practice Hereditary cancer in clinical practice, 6(1), 3-14. BioMed Central Ltd. |
| ISSN: | 1731-2302 |
| Popis: | In this paper we review clinical and genetic aspects of testicular germ cell tumours (TGCTs). TGCT is the most common type of malignant disorder in men aged 15-40 years. Its incidence has increased sharply in recent years. Fortunately, survival of patients with TGCT has improved enormously, which can chiefly be attributed to the cisplatin-based polychemotherapy that was introduced in the nineteen eighties to treat patients with metastasized TGCT. In addition, new strategies have been developed in the surgical approach to metastasized/non-metastasized TGCT and alterations have been made to the radiotherapy technique and radiation dose for seminoma. Family history of TGCT is among the strongest risk factors for this tumour type. Although this fact and others suggest the existence of genetic predisposition to develop TGCT, no germline mutations conferring high risk of developing TGCT have been identified so far. A small deletion, referred to as gr/gr, identified on the Y chromosome is probably associated with only a modest increase in TGCT risk, and linkage of familial TGCT to the Xq27 region has not been confirmed yet. Whether highly penetrant TGCT-predisposing mutations truly exist or familial clustering of TGCT can be explained by combinations of weak predispositions, shared in utero or postnatal risks factors and coincidental somatic mutations is an intriguing puzzle, still waiting to be solved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink